Askim, Sweden

Annie H Mattsson

This inventor holds 1 USPTO granted patent. Top assignee: Aktiebolaget Hassle. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annie H Mattsson. Retrieved from https://idiyas.com/inventor/annie-h-mattsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Annie H. Mattsson: Innovator in Anti-Ulcer Agents

Introduction: Annie H. Mattsson, a notable inventor based in Askim, Sweden, is recognized for her contributions to the pharmaceutical industry. With a singular patent to her name, her innovative work focuses on developing novel compounds aimed at treating ulcers effectively.

Latest Patents: Mattsson holds a patent titled "Derivatives of benzimidazoles active as anti-ulcer agents." This groundbreaking patent describes novel compounds of the general formula I, detailing the processes for their preparation, pharmaceutical compositions incorporating these compounds, and their applications in medicine.

Career Highlights: Throughout her career, Annie has made significant strides in pharmaceutical research. She is associated with Aktiebolaget Hassle, where she has been pivotal in advancing research that leads to effective treatments for gastrointestinal conditions.

Collaborations: One of her key collaborations includes working with her coworker, Carin B. Briving. Together, they have contributed to the development of innovative pharmaceutical solutions, combining their expertise to enhance patient care and treatment outcomes.

Conclusion: Annie H. Mattsson exemplifies the spirit of innovation in the pharmaceutical field. Her work on anti-ulcer agents not only highlights her dedication to research and development but also her commitment to improving health outcomes through her innovative inventions. As she continues her work, Mattsson remains a figure to watch in the realm of pharmaceutical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…